Article
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
European journal of cancer (Oxford, England : 1990) - 1 Sept 2018
Goey Kaitlyn K H, Sørbye Halfdan, Glimelius Bengt, Adams Richard A, André Thierry, Arnold Dirk, Berlin Jordan D, Bodoky György, de Gramont Aimery, Díaz-Rubio Eduardo, Eng Cathy, Falcone Alfredo, Grothey Axel, Heinemann Volker, Hochster Howard S, Kaplan Richard S, Kopetz Scott, Labianca Roberto, Lieu Christopher H, Meropol Neal J, Price Timothy J, Schilsky Richard L, Schmoll Hans-Joachim, Shacham-Shmueli Einat, Shi Qian, Sobrero Alberto F, Souglakos John, Van Cutsem Eric, Zalcberg John, van Oijen Martijn G H, Punt Cornelis J A, Koopman Miriam
Abstract excerpt
BACKGROUND: Patient characteristics and stratification factors are key features influencing trial outcomes. However, there is substantial heterogeneity in reporting of patient characteristics and use of stratification factors in phase 3 trials investigating systemic treatment of metastatic colorectal cancer (mCRC). We aimed to develop a minimum set of essential baseline characteristics and stratification factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.